Genomics
GTC was honored to be featured in the Orange County Business Journal
GTC featured in the Orange County Business Journal on September 30, 2019 [Click image to enlarge]
October 16, 2019 10:24 am
Read More »
Innovation
Do not Accept partial results about PH-Like Acute Lymphoblastic Leukemia
Distinguishing PH-like acute lymphoblastic leukemia (ALL) from other types of ALL relies on full evaluation of the molecular abnormalities in the leukemic cells. Order GTC
October 1, 2019 10:16 pm
Innovation
Time Matters on Health Tests [TAT-NGS]
We’re always competing with ourselves on improving turn around time (TAT) because we know patients depend on the results Most studies suggest that treatment delay
July 17, 2019 11:31 am
Press Releases
Myelodysplastic Syndrome (MDS)
MDS is defined as ineffective hematopoiesis characterized by adequate or increased hematologic elements in bone marrow with peripheral cytopenia. Therefore, the presence of cytopenia in
June 26, 2019 3:00 am
Press Releases
Genomic Testing Cooperative Receives Medicare (Palmetto GBA) Coverage for two NGS Hematology Molecular Profiling Tests Including Liquid Biopsy for Hematologic Neoplasms
GTC Receives Medicare Coverage for 2 NGS Hematology Molecular Profiling Tests Including Liquid Biopsy for Hematologic Neoplasms Irvine, California– June 19, 2019 – Genomic Testing
June 19, 2019 3:50 am
Press Releases
Comprehensive testing for breast cancer evaluating DNA and RNA
Genomic Testing cooperative (GTC) provides a comprehensive genomic profiling of breast cancer including evaluating: – Actional mutations – Gene amplification and deletion – Hormonal expression
September 23, 2024 11:21 am
Press Releases
Comprehensive PIK3CA Mutation Analysis
(FOR UPDATED INFORMATION ABOUT COMPREHENSIVE TESTING FOR BREAST CANCER VISIT THIS PAGE: Comprehensive testing for breast cancer evaluating DNA and RNA) When you order GTC
June 4, 2019 10:00 am
Press Releases
The FDA has Approved Drugs for FGFR Abnormalities
The FDA has approved Balversa (erdafitinib) as a treatment for adult patients with locally advanced or metastatic bladder cancer that have FGFR3 or FGFR2 abnormalities
May 27, 2019 11:00 am
Press Releases
GTC Presents at the 2019 ASCO Annual Meeting
Genomic Testing Cooperative (GTC) and Collaborators to Present data Resulting from its Proprietary DNA and RNA Profiling of Diffuse Large B-cell Lymphoma at the 2019
May 22, 2019 4:00 am
Press Releases
Study shows that RNA Plus DNA profiling significantly enhanced Drug Matching
Recent study published in Nature Medicine (Rodon et al, Nature Medicine volume 25, pages 751–758, 2019) showed that molecular profiling using both DNA and RNA
May 16, 2019 9:18 am